PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 MEASUREMENT IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE
Aim. To assess the levels of serum fibrosis marker (galectin-3) in patients with metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD)Material and methods. Totally 76 patients included, 43 with MS, of those 72,1% had the NAFLD diagnosed; 33 patients without MS and NAFLD (controls), m...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2015-10-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/164 |